Adrian Daneri-Navarro
Overview
Explore the profile of Adrian Daneri-Navarro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
543
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chavarri-Guerra Y, Ferrigno-Guajardo A, Villarreal-Garza C, Martinez-Cannon B, Abugattas-Saba J, Fontaine A, et al.
JCO Glob Oncol
. 2024 Oct;
10:e2400097.
PMID: 39481075
Purpose: Women with pathogenic variants (PVs) in breast cancer (BC) and ovarian cancer (OC) associated genes are candidates for cancer risk-reducing strategies. Limited information is available regarding risk-reducing surgeries (RRS)...
2.
Gutierrez-Zepeda B, Gomez-Del Toro M, Ortiz-Soto D, Becerra-Loaiza D, Quiroz-Bolanos A, Topete A, et al.
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337657
Breast cancer (BC) is the leading cause of death from tumors in women worldwide, influenced by various factors, including genetics. The T allele of the single nucleotide variant (SNV) rs3025039...
3.
Alves da Quinta D, Rocha D, Retamales J, Giunta D, Artagaveytia N, Velazquez C, et al.
Oncologist
. 2024 Aug;
29(12):e1701-e1713.
PMID: 39115892
Background: Several guidelines recommend the use of different classifiers to determine the risk of recurrence (ROR) and treatment decisions in patients with HR+HER2- breast cancer. However, data are still lacking...
4.
Retamales J, Daneri-Navarro A, Artagaveytia N, Alves da Quinta D, Abdelhay E, Podhajcer O, et al.
JCO Glob Oncol
. 2024 May;
10:e2300216.
PMID: 38723219
Purpose: Breast cancer mortality rates in Latin America (LA) are higher than those in the United States, possibly because of advanced disease presentation, health care disparities, or unfavorable molecular subtypes....
5.
14 bp Ins/Del (rs66554220) Variant Is Not Associated with Breast Cancer in Women from Western Mexico
Becerra-Loaiza D, Roldan Flores L, Ochoa-Ramirez L, Gutierrez-Zepeda B, Del Toro-Arreola A, Franco-Topete R, et al.
Curr Issues Mol Biol
. 2023 Aug;
45(8):6842-6850.
PMID: 37623251
HLA-G is a physiology and pathologic immunomodulator detrimentally related to cancer. Its gene is heavily transcriptionally and post-transcriptionally regulated by variants located in regulator regions like 3'UTR, being the most...
6.
Oceguera-Basurto P, Figueroa-Ochoa E, Anguiano-Sevilla L, Sanchez-Ramirez D, Quintero-Ramos A, Del Toro-Arreola A, et al.
Int J Pharm
. 2023 Jun;
642:123175.
PMID: 37369286
Breast cancer (BC) has surpassed lung cancer as the most diagnosed cancer and, in terms of mortality, is the fifth leading cause with 684,996 new deaths (6.7% of all cancer-related...
7.
de Almeida L, Cortes S, Vilensky M, Valenzuela O, Cortes-Sanabria L, de Souza M, et al.
Front Oncol
. 2022 May;
12:845527.
PMID: 35530311
Molecular profile of breast cancer in Latin-American women was studied in five countries: Argentina, Brazil, Chile, Mexico, and Uruguay. Data about socioeconomic characteristics, risk factors, prognostic factors, and molecular subtypes...
8.
Llera A, Abdelhay E, Artagaveytia N, Daneri-Navarro A, Muller B, Velazquez C, et al.
Front Oncol
. 2022 Apr;
12:835626.
PMID: 35433488
Purposes: Most molecular-based published studies on breast cancer do not adequately represent the unique and diverse genetic admixture of the Latin American population. Searching for similarities and differences in molecular...
9.
Oceguera-Basurto P, Topete A, Oceguera-Villanueva A, Rivas-Carrillo J, Paz-Davalos M, Quintero-Ramos A, et al.
Transl Cancer Res
. 2022 Feb;
9(7):4444-4456.
PMID: 35117809
The detection of premenopausal women at high risk of breast cancer is key to chemoprevention. Therapy with selective estrogen receptor modulators (SERMs) induces a significant antiproliferative effect in estrogen receptor...
10.
Herzog J, Chavarri-Guerra Y, Castillo D, Abugattas J, Villarreal-Garza C, Sand S, et al.
NPJ Breast Cancer
. 2021 Aug;
7(1):107.
PMID: 34413315
The prevalence and contribution of BRCA1/2 (BRCA) pathogenic variants (PVs) to the cancer burden in Latin America are not well understood. This study aims to address this disparity. BRCA analyses...